Lung Cancer
Edward S. Kim, MD, joins Friends of Cancer Research board of directors
Friends of Cancer Research appointed Edward S. Kim, MD, MBA, FACP, FASCO, to its board of directors.
Osimertinib extends survival in early EGFR-mutated non-small cell lung cancer
Osimertinib conferred a statistically significant and clinically meaningful improvement in OS compared with placebo among patients with early-stage EGFR-mutated non-small cell lung cancer, according to the agent’s manufacturer.
Expanded lung cancer screening eligibility criteria could benefit women, Black individuals
An expansion of lung cancer screening criteria to include those who are younger and with less smoking exposure would increase eligibility for women and Black individuals who could benefit, results of a retrospective study showed.
FDA grants 510(k) clearance to robotic navigated bronchoscope system
The FDA has granted 510(k) clearance to a robotic navigated bronchoscopy system that will aid in diagnosing patients with lung cancer, according to a manufacturer-issued press release.
Menopausal hormone therapy does not increase lung cancer risk
Women using hormone therapy for menopause symptoms did not have a greater risk for lung cancer than their untreated peers, and may have had lower risk with higher HT dosage and duration, according to study data published in Menopause.
Phase 3 trials of pembrolizumab in prostate, lung cancer miss primary endpoints
Two phase 3 trials evaluating pembrolizumab in combination with additional agents failed to meet their primary endpoints, according to the agent’s manufacturer.
Healio | HemOnc Today announces new physician leadership
Optimizing CV health behaviors may lower risk for CVD and cancer
Improvement in the American Heart Association’s Life’s Simple 7 CV health score was associated with lower risk for cancer and CVD during nearly 25 years of follow-up, researchers reported.
All-cause, CVD mortality highest in Black patients among those with cancer
Researchers observed significant racial disparities in all-cause and CVD mortality among adults with cancer, with wider gaps found among patients younger than 55 years, according to a study published in JACC: CardioOncology.
Early-life exposure to tobacco raises risk for lung cancer, mortality in adulthood
Being exposed to tobacco in utero and in childhood/adolescence was linked to higher risks for lung cancer incidence and death later in life, according to study results published in American Journal of Respiratory and Critical Care Medicine.